or Try an Advanced Search...

    Technical Analysis for SHPH - Shuttle Pharmaceuticals Holdings, Inc.

    Grade Last Price % Change Price Change
    F 0.40 -0.03% 0.00
    SHPH closed down 0.03 percent on Monday, July 1, 2024, on 71 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical SHPH trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.03%
    Outside Day Range Expansion -0.03%
    Wide Bands Range Expansion -0.03%
    Gapped Up Strength -0.03%
    Oversold Stochastic Weakness -0.03%
    Wide Bands Range Expansion 5.18%
    Older End-of-Day Signals for SHPH ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 6 hours ago
    Possible Inside Day about 6 hours ago
    Up 1% about 7 hours ago
    60 Minute Opening Range Breakdown about 7 hours ago
    Fell Below 10 DMA about 7 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SHPH Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Cancer Radiation Radiation Therapy Sarcoma Brain Tumor Soft Tissue Sarcoma Liver Cancer

    Is SHPH a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 18 Shuttle Pharma names Timothy Lorber as CFO
    Jun 18 Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer
    May 22 Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
    May 14 Shuttle Pharmaceuticals reports Q1 results
    May 14 Shuttle Pharma Provides First Quarter 2024 Corporate Update
    Apr 29 Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV
    Apr 23 Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
    Apr 5 Shuttle Pharmaceuticals files to sell subscription rights to buy $4.5M in units
    Apr 3 Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024
    Apr 3 Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
    See more SHPH news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.23
    52 Week Low 0.35
    Average Volume 55,940
    200-Day Moving Average 0.46
    50-Day Moving Average 0.43
    20-Day Moving Average 0.43
    10-Day Moving Average 0.39
    Average True Range 0.04
    RSI (14) 45.05
    ADX 22.45
    +DI 10.18
    -DI 13.78
    Chandelier Exit (Long, 3 ATRs) 0.46
    Chandelier Exit (Short, 3 ATRs) 0.49
    Upper Bollinger Bands 0.53
    Lower Bollinger Band 0.33
    Percent B (%b) 0.34
    BandWidth 44.86
    MACD Line -0.02
    MACD Signal Line -0.01
    MACD Histogram -0.0042
    Fundamentals Value
    Market Cap 6.39 Million
    Num Shares 16 Million
    EPS -0.40
    Price-to-Earnings (P/E) Ratio -1.00
    Price-to-Sales 0.00
    Price-to-Book 1.08
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.44
    Resistance 3 (R3) 0.43 0.42 0.43
    Resistance 2 (R2) 0.42 0.41 0.42 0.43
    Resistance 1 (R1) 0.41 0.40 0.41 0.41 0.43
    Pivot Point 0.39 0.39 0.40 0.40 0.39
    Support 1 (S1) 0.38 0.39 0.39 0.39 0.37
    Support 2 (S2) 0.37 0.38 0.37 0.37
    Support 3 (S3) 0.36 0.37 0.37
    Support 4 (S4) 0.36